Financial Performance and Strategy - The company is raising its FY26 adjusted EPS outlook to $3805-$3855, previously $3710-$3790[283] - The company anticipates free cash flow between $44 billion and $48 billion[283] - The company projects North American Pharmaceutical revenue growth of 10% to 14% and adjusted operating profit growth of 3% to 7%[284] - Oncology & Multispecialty revenue is expected to grow by 27% to 31%, with adjusted operating profit increasing by 49% to 53%[284] - Prescription Technology Services anticipates revenue growth of 9% to 13% and adjusted operating profit growth of 11% to 15%[284] Market Dynamics and Portfolio Evolution - The US pharmaceutical market is projected to reach $1156 billion in 2029, with a CAGR of +7%[107] - The Canadian Pharma Rx Market is projected to reach $67 billion (CAD) in 2029, with a CAGR of +7%[146] - Specialty spend in the US Pharmaceutical sector is growing, with oncology expected to increase by +60% and immunology by +39%[110] Biopharma Services - The biopharma services market presents a $19 billion opportunity[214] - The company's solutions enable >$10 billion of out-of-pocket savings for patients annually[53] - The company's solutions prevent 12 million prescriptions from abandonment[53]

INVESTOR DAY September 23, 2025 © 2025 SPS Commerce Today's Agenda Growth Strategy | Chad Collins, CEO Product Strategy | Mike Svatek, CPO Financial Review | Kim Nelson, CFO Go-to-Market Strategy | Chad Collins, CEO Break Moderated Customer Panel Q&A Network Strategy | Jamie Thingelstad, CTO © 2025 SPS Commerce 2 Agenda Forward-Looking Statements and Non-GAAP Financial Measures This presentation contains forward-looking statements, including information about management's view of SPS Commerce's future expec ...

Transaction Overview - ADS will acquire National Diversified Sales (NDS) for approximately $1 billion, or $875 million when adjusted for expected tax benefits[9] - The transaction value represents a multiple of 10x NDS Adjusted EBITDA from TTM ended June 2025, inclusive of expected run-rate cost synergies[9] - Approximately $25 million of annual cost synergies are expected to be realized by year 3[9, 35] - The transaction is expected to close in the first quarter of CY2026[9] NDS Overview - NDS is a leading U S supplier of residential stormwater management, landscape irrigation and connecting flow management components for water infrastructure[10] - Landscape Irrigation accounts for approximately 30% of NDS' business mix, while Flow Management accounts for approximately 15%[12] - The Americas account for 90% of NDS' geographic revenue[12] Financial Impact - Pro forma net sales including $25 million cost synergies is approximately $3 2 billion[34] - Pro forma adjusted EBITDA including $25 million cost synergies is approximately $980 million[34] - Pro forma adjusted EBITDA margin including $25 million cost synergies is approximately 31%[34]

Table of contents Hichem M'Saad CEO Vamsi Paruchuri Corporate VP, Technology Innovation and Market Research Enabling customers with Angstrom precision through service innovation and automation From layers to landscape: Opportunities and growth through technology inflections Atoms to action: Our growth strategy to 2030 Page 4 Page 44 Page 70 Jason Foster Corporate VP, Spares and Service Business Unit, Global Quality and Technical Training Investor Day 2025 We explore atoms, so others can explore space Index ...

Acquisition Overview - HEINEKEN will acquire FIFCO's beverage and retail businesses to strengthen its presence across Central America[1] - The acquisition includes 100% ownership of HEINEKEN Panama and expands HEINEKEN's regional footprint[7] - The cash consideration for the stakes acquired by HEINEKEN will be US$3.2 billion[44] Strategic Rationale - The acquisition advances HEINEKEN's EverGreen strategy by strengthening its Central American footprint[10] - HEINEKEN aims to re-allocate resources to growth opportunities through strategic acquisitions and disposals[14] - The transaction is expected to be immediately accretive to operating profit and EPS[44] Market Position and Growth - HEINEKEN will acquire 100% control of the beverage leader in Costa Rica[10] - HEINEKEN Panama experienced a compound annual growth rate (CAGR) of approximately 20% in beer volume from 2019 to 2024[10, 34] - Costa Rica is a highly attractive market with strong macro fundamentals and favorable beverage consumption trends[17] Financial Impact and Synergies - The implied acquisition multiple is 116x EV/EBITDA based on 2024 results[44] - Run-rate cost savings of approximately US$50 million are anticipated[44] - Costa Rica will be one of HEINEKEN's top 5 operating companies by operating profit[44] Central America Expansion - HEINEKEN has an equal partnership (4985%) in Nicaragua's leading brewer[8, 38] - HEINEKEN has a food & beverage platform in Guatemala[8, 38] - HEINEKEN has a fast-growing Beyond Beer portfolio in Mexico[8, 38]

Financial Performance & Strategy - The company is focused on sustainable income/EPS growth, built on a high-quality portfolio[5] - FY26 EPS is expected to grow approximately 2-4% before a 0.9 pence impact from the Queen Anne's Mansions (QAM) disposal[8, 39] - The company aims for long-term LFL NRI growth exceeding inflation, driven by structural demand growth and supportive policies[9] - The company is prioritizing capital allocation based on a clear view of risks/returns, with a focus on income and income growth[16, 19] - The company is recycling capital from low-returning assets, having monetized £644 million of low-returning capital employed at a cost to NTA of 1%[19, 23] Retail Portfolio & Growth Drivers - Major retail contributes 38% of total income and has strong income growth potential, underpinning overall EPS growth[8, 34] - The company targets a CAGR of 4.5-7.0% for major retail NRI from FY25-30, driven by capturing reversion & turnover growth, commercialization, and accretive capex[35] - The company's retail portfolio has 86% of its assets in the top 1% of UK retail destinations[44] - The company's sales growth has outperformed the UK market by 13% over the last 3 years[48] - The company aims to grow £21 million in commercialization income by over 50%, adding 0.5-1% to NRI growth per annum[79]

Financial Performance - Q4 FY2025 revenue increased to $2.8 million, a 183% increase from $1.0 million in Q3 FY2025[13] - FY2025 revenue substantially increased to $4.3 million, a 1,149% increase from $0.3 million in FY2024[13] - FY2025 cash cost of goods sold increased by 483% to $10.5 million, compared to $1.8 million in FY2024, which is far below the rate of revenue growth[13] - FY2025 total operating expenses decreased 30% to $31.4 million, from $44.8 million in FY2024[13] - The company's cash balance was $25.4 million as of September 15, 2025[13] Battery Recycling Business - Q4 throughput at the first battery recycling facility increased 70% over Q3[17] - The company completed all requirements in its contract with the U S Advanced Battery Consortium (USCAR) in FY2025[17] - The company was awarded a $144 million grant from the U S DOE for the construction of a second battery recycling facility[17] Claystone to LiOH Business - The company successfully manufactured battery-grade lithium hydroxide from Nevada-based claystone at its multi-tonne per day integrated pilot facility[24] - The company completed all requirements in its $2.3 million grant award from the U S DOE for the claystone to lithium hydroxide pilot facility[25] - The company designed a commercial scale lithium refinery as part of its Tonopah Flats Lithium Project to manufacture 30,000 tonnes of lithium hydroxide per year[25] Other Highlights - The company's Tonopah Flats Lithium Project was selected as a Transparency Priority Project and a Covered Project to streamline permitting processes[28] - The company received an approved Letter of Interest from the US Export-Import Bank for a $900 million low-interest loan for the Tonopah Flats Lithium Project[28]

Acquisition Overview - SunPower is acquiring Sunder Energy to become the No 5 solar company in the US[26] - The consideration for Sunder is $40 million in cash and 10 million shares valued at $555 million (at $155 per share)[27] Financial Projections & Synergies - Sunder is projected to contribute $74 million in sales revenue in 2025[27] - Sunder's EPC customer revenue is $173 million, with 50% ($865 million) expected to be captured by Q4 2026[27] - Sunder's 2026 revenue contribution is modeled to be $128 million, including $74 million from sales and $54 million from EPC[27] - The acquisition is expected to increase SunPower's revenue per employee from $333K to $4201 million per year[46, 48] Sales & Market Expansion - Sunder brings a sales force of 893 salespeople, doubling SunPower's sales force to 1,734[42] - The acquisition expands SunPower's coverage from 22 to 45 states[39, 42] - Sunder's revenue per install is $40,000, higher than the industry average and SunPower's $35,000[42] - Sunder's order/install yield is 55%, better than the industry average and SunPower's 45%[42] Strategic Goals - SunPower aims to grow from $300 million in 2025 to $1 billion in 2028[49] - SunPower projects Q3 2025 revenue of $70 million and aims to grow to $250 million by Q3 2028[49] - SunPower anticipates achieving record revenue in Q4 2025 with the help of Sunder[58]

Transaction Overview - Black Diamond Group will acquire 100% of Royal Camp Services Ltd for $165 million[5] - The consideration includes up to 4,000,000 common shares of BDI at a deemed price of $12.08 per share[5] - The valuation basis is at the mid-point range of $31-$41 million three-year Adjusted EBITDA[5] - The transaction is expected to close by the end of 2025, subject to Competition Act clearance[5] Royal Camp Services - Royal Camp Services has 34 years of experience as a provider of workforce accommodations and catering services[5] - Royal Camp Services has approximately 580 employees, including over 250 Indigenous employees[5] - Royal Camp Services has approximately 2,000 units with approximately 6,500 beds of capacity and three open camps in Northeastern BC[5] Strategic Rationale - The acquisition will create a premier integrated workforce accommodations & catering/hospitality business[5] - The acquisition is expected to be highly accretive and contribute to growing free cashflow generation due to acquisition synergies and increasing market demand[5] - The combined business is expected to retain all team members[6] Market Tailwinds - Strengthening market dynamics are expected to drive increased demand for remote and workforce accommodations assets[14] - Nation building projects, defense & military spending, and energy & mining projects are expected to drive demand[15]

Progranulin (PGRN)-Elevating Franchise - Alector's pivotal Phase 3 data readout for Latozinemab (AL001) in FTD-GRN is expected by mid-Q4 2025[13, 65] - The Phase 2 clinical trial for Nivisnebart (AL101/GSK4527226) in Alzheimer's Disease completed enrollment in April 2025[13, 68] - Latozinemab and nivisnebart have demonstrated a 2- to 3-fold increase in PGRN levels in clinical trials[50] - In the INFRONT-2 trial, Latozinemab treatment showed an estimated ~48% slowing of annual disease progression in FTD-GRN participants compared to historical controls, representing a 31-point change[61] Alector Brain Carrier (ABC) Platform - Alector expects to initiate a first-in-human clinical trial with its Alector Brain Carrier in 2026[13, 120] - AL037, an ABC-enabled anti-Aβ antibody, at 3mg/kg reached 38 nM in vessel-containing frontal cortex in NHP, showing an 18x increase compared to the naked antibody[114] - AL137, a second anti-Aβ antibody lead, at 3mg/kg reached 84 nM in vessel-containing frontal cortex in NHP, showing a 32x increase compared to the naked antibody[117] - AL050, an ABC-enabled GCase ERT, demonstrated a 5- to 19-fold enhancement in brain delivery in NHPs[149] - Peripheral delivery of SOD1 siRNA-ABC resulted in 50-80% knockdown across multiple brain structures in mice[171] Financial Resources - Alector has over $300 million in cash, providing a runway into the second half of 2027[13]